Black Diamond Therapeutics (BDTX) P/E (2020 - 2026)
Black Diamond Therapeutics (BDTX) P/E from Jan 30, 2020 to Jul 21, 2026. The TTM Black Diamond Therapeutics (BDTX) P/E is -2.47. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Black Diamond Therapeutics (BDTX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.47 | -140.45% |
| 2025 | 6.10 | -458.69% |
| 2024 | -1.70 | +28.40% |
| 2023 | -1.33 | +94.68% |
| 2022 | -0.68 | -55.68% |
| 2021 | -1.54 | -91.04% |
| 2020 | -17.15 | N/A |
Comparison Black Diamond Therapeutics (BDTX) P/E with competitors
Black Diamond Therapeutics (BDTX) P/E is -2.47.